PROCAPS GROUP S.A.

PROC
Delayed Nasdaq - 03:22 2022-12-01 pm EST
6.500 USD +0.46%

Turn to zoom
Prev.6.50000000
Open6.30000000
High6.65000000
Low6.30000000
Volume3 448
Latest news
11/14
11/14
11/14
11/08
Chart PROCAPS GROUP S.A.
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishBearish
Resistance6,937,897,93
Spread/Res.-6,2%-18%-18%
Spread/Supp.3,8%14%15%
Support6,265,685,65
Financials
Sales 2022 444 M - -
Net income 2022 46,0 M - -
Net Debt 2022 83,0 M - -
P/E ratio 2022 15,8x
Yield 2022 -
Capitalization 730 M 730 M -
EV / Sales 2022 1,83x
EV / Sales 2023 1,60x
Nbr of Employees 5 300
Free-Float 15,3%
Company
Procaps Group SA is a Luxembourg-based healthcare and pharmaceutical company. The Company develops, manufactures and sells prescription drugs and products that are differentiated by their combinations and pharmaceutical forms, as well as nutritional supplements which include omega 3 fish oils and...
Sector :
Other Holding Companies
Calendar :
2023-05-01 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 6,47 $
Average target price 12,00 $
Spread / Average Target 85,5%